Search

everythinglearnresearchcommunity

for

Search:↓

Age, diabetes, and cardiogenic shock at PCI are key factors linked to in-hospital death in STEMI patients with hypertension.

Gefitinib can cause scalp skin issues and permanent hair loss.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

EGF receptors are crucial for skin cell growth and decrease with age.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

PDGF signaling is crucial for cell development, wound healing, and fluid regulation in the body.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Targeting specific cell interactions may help treat skin fibrosis.

Androgen receptors help prostate cancer cells grow and resist drugs.